Summary
Cardinal Health Inc. (CAH) reported strong revenue growth of 9% for the three months ending September 30, 2005, reaching $19.37 billion, indicating broad-based demand across its four key segments. While net earnings saw a modest increase of 7% to $228.3 million, diluted earnings per share grew by 8% to $0.53. The company adopted new accounting standards for share-based payments (SFAS 123(R)) starting this quarter, significantly increasing equity-based compensation expense by $82.9 million compared to the prior year, which impacted reported operating earnings. Despite this, the company continues to execute its "One Cardinal Health" global restructuring program, aiming for approximately $190 million in operating earnings improvement in fiscal year 2006. Management highlighted strength in its Clinical Technologies and Services segment, particularly the Pyxis products business, and noted a significant increase in "Bulk Revenue" within its Pharmaceutical Distribution segment.
Key Highlights
- 1Revenue increased by 9% to $19.37 billion for the quarter ended September 30, 2005, driven by growth across all segments.
- 2Net earnings grew by 7% to $228.3 million, resulting in diluted EPS of $0.53, an 8% increase year-over-year.
- 3Adoption of SFAS 123(R) led to a significant increase in equity-based compensation expense to $82.9 million, impacting operating earnings.
- 4The global restructuring program is progressing, with expected operating earnings improvement of $190 million in fiscal year 2006.
- 5The Pharmaceutical Distribution and Provider Services segment saw a substantial 24% increase in "Bulk Revenue".
- 6Clinical Technologies and Services segment showed strong performance with 88% operating earnings growth, boosted by the Pyxis products business.
- 7The company recorded a $25 million reserve for the ongoing SEC investigation.